You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CUE Sale Disclosure
Lin Shao-lee · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$66.76K
Lin Shao-lee Chief Executive Officer
CUE
Cue Biopharma
CUE
Transaction date
Aug 13, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 1 day later
CUE daily price context
Close on/before transaction
$31.08
Aug 13, 2026
First close after public filing
$27.64
Aug 17, 2026
30-day return after filing
+10.53%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,375 shares @ $28.11
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001725092-26-000013
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$1.61M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cue Biopharma, Inc. CUE | Sale | Aug 13, 2026 | $147.45K |
| Cue Biopharma, Inc. CUE | Sale | Aug 13, 2026 | $308.36K |
| Cue Biopharma, Inc. CUE Current | Sale | Aug 13, 2026 | $66.76K |
| Cue Biopharma, Inc. CUE | Sale | Aug 12, 2026 | $923.73K |
| Cue Biopharma, Inc. CUE | Exercise | Aug 12, 2026 | $0 |
| Cue Biopharma, Inc. CUE | Sale | Aug 12, 2026 | $160.26K |
| Cue Biopharma, Inc. CUE | Exercise | Aug 12, 2026 | $0 |